WuXi Biologics (Cayman) Inc (WXXWY)
3.33
+0.06
(+1.74%)
USD |
OTCM |
Apr 17, 15:59
WuXi Biologics Total Liabilities (Quarterly): 1.772B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.772B |
June 30, 2023 | 1.806B |
June 30, 2023 | 1.806B |
December 31, 2022 | 1.935B |
June 30, 2022 | 1.789B |
June 30, 2022 | 1.789B |
December 31, 2021 | 1.777B |
June 30, 2021 | 1.546B |
June 30, 2021 | 1.546B |
December 31, 2020 | 1.234B |
June 30, 2020 | 979.44M |
Date | Value |
---|---|
June 30, 2020 | 979.44M |
December 31, 2019 | 672.62M |
June 30, 2019 | 242.15M |
June 30, 2019 | 242.15M |
December 31, 2018 | 203.36M |
June 30, 2018 | 159.80M |
June 30, 2018 | 159.80M |
December 31, 2017 | 126.30M |
June 30, 2017 | 266.65M |
June 30, 2017 | 266.65M |
December 31, 2016 | 246.86M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
242.15M
Minimum
Jun 2019
1.935B
Maximum
Dec 2022
1.341B
Average
1.546B
Median
Jun 2021
Total Liabilities (Quarterly) Benchmarks
Wuxi AppTec Co Ltd | 2.561B |
Zai Lab Ltd | 240.18M |
I-MAB | 146.81M |
Gracell Biotechnologies Inc (DELISTED) | 36.85M |
Sinovac Biotech Ltd | 1.488B |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 7.981B |
Shareholders Equity (Quarterly) | 5.690B |
Debt to Equity Ratio | 0.0532 |
Current Ratio | 2.776 |
Net Debt Paydown Yield | 0.27% |